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Abbreviations: ALP, alkaline phosphatase; CAPE, caffeic acid phenyl ester; CSMe, Citrus 
sinensis fruit peel methanol extract; DWP, dry weight peel; FBG, fasting blood glucose; 
HDL-c, high-density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of 
insulin resistance; HRP, horseradish peroxidase; ITT, insulin tolerance test; LDL-c, low-
density lipoprotein cholesterol; OGTT, oral glucose tolerance test; PBS, phosphate-buffered 
saline; PBST, phosphate-buffered saline-Tween 20; RSD, relative standard deviation; SEM, 
standard error of the mean; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum 
glutamic pyruvic transaminase; STZ, streptozotocin; T2DM, type 2 diabetes mellitus; TC, 
total cholesterol; TG, triglycerides.  
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ABSTRACT 
Citrus sinensis (L.) Osbeck  is extensively cultivated worldwide and one of the most 
consumed fruits in the world. We evaluated the therapeutic properties of the methanol extract 
from Citrus sinensis fruit peel (CSMe) in high-fat diet-fed streptozotocin-induced insulin-
resistant diabetic rats. Body weight, food intake, and water consumption were analysed. 
Biochemical and molecular biologic indices, and the expression of insulin receptor-induced 
signalling molecules were assessed to identify possible mechanisms. In addition, we 
conducted histology of pancreatic and adipose tissues. UHPLC-MS/MS analysis showed the 
presence of 17 dietary phenolics at substantial concentrations. High-fat diet-fed 
streptozotocin-induced diabetic rats administered CSMe (50 and 100 mg/kg) had reduced 
fasting blood glucose (56.1% and 55. 7%, respectively) and plasma insulin levels (22.9% and 
32.7%, respectively) compared with untreated diabetic control rats. CSMe reversed the 
biochemical abnormalities in diabetic rats, showed cytoprotective activity, and increased the 
intensity of the positive immunoreactions for insulin in pancreatic islets. CSMe treatment 
increased the expression of PPARγ in the adipose tissue and signalling molecules GLUT4 
and insulin receptor. Our data suggest that CSMe could optimize glucose uptake of adipose 
tissues through the insulin-dependent signalling cascade mechanism and it should be 
investigated in the management of individuals with type 2 diabetes mellitus. 
 
Keywords: Adipose; Citrus sinensis; Diabetes; Histology; Insulin receptor; Pancreatic β-cell 
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1. Introduction 
     Type 2 diabetes mellitus (T2DM) is one of the most prevalence chronic diseases resulting 
in severe complications, such as nephropathy, neuropathy, retinopathy, cardiovascular 
morbidity and premature mortality (Dewanjee et al., 2009). Its relenting increase worldwide 
imposes a huge financial burden on healthcare systems (Seuring et al., 2015). T2DM is 
characterised by pancreatic β-cell dysfunction, hyperglycaemia, and dyslipidaemia that result 
from metabolic deregulations, inappropriate glucose utilization and distortion of the insulin 
signalling pathway (Sharma et al., 2008). Natural products are a common source of new 
chemical or therapeutic molecules for T2DM (Newman and Cragg, 2012; 2016). Many plants 
are used in ethnopharmacology to treat symptoms of T2DM, including several polyphenolic 
compounds such as fukugetin, palmatine, berberine and others (Rios et al., 2015; Gushiken et 
al., 2016). Moreover, many natural products can stimulate insulin signalling with possible 
applicability to T2DM, resulting in a growing number of patents (Singh and Mahajan, 2013; 
Salimifar et al., 2013; Tamrakar et al., 2014).  
     Citrus sinensis (L.) Osbeck (Rutaceae), commonly known as the sweet orange, is 
ubiquitous in human diet across the world (Lv et al., 2015) and belongs to the citrus family 
(Duarte et al., 2016). C. sinensis peel is a rich source of phenolic compounds, with 
antidiabetic, antioxidant, and free radical scavenging activities, effects against 
gastrointestinal illnesses, and potential protection against different cancers and cardiovascular 
disorders (Rotelli et al., 2003; Selmi et al., 2017). A number of  recent experiments have 
explored the therapeutic potential of phenolics derived from citrus species as a single 
bioactive molecule (Selmi et al., 2017). C. sinensis peel exhibits hypoglycaemic and 
hypolipidaemic effects in an alloxan-induced animal model of type 1 diabetes (Luka et al., 
2017). However, no comprehensive studies have explored the therapeutic potential of the 
standardised extract of C. sinensis peel in high-fat diet-fed rats with streptozotocin (STZ)-
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induced type 2 diabetes. Therefore, the present investigation was designed to analyse the 
phenolic composition and antidiabetic effect of C. sinensis peel and evaluate its effects on 
insulin receptor-induced signalling in a rat model of obesity and T2DM.  
2. Material and methods  
2.1. Chemicals and reagents 
    Methanol and acetonitrile were purchased from Merck (New Jersey, USA). The water used 
for the mobile phase was purified by using a Milli-Q system (Direct-Q® 3UV, Millipore, São 
Paulo, Brazil). STZ, apigenin, artepillin C, cinnamic acid, caffeic acid, ferulic acid, caffeic 
acid phenyl ester (CAPE), (+)-catechin, ethyl gallate, kaempferide, acacetin, naringenin, p-
coumaric acid, protocatechuic acid, chrologenic acid, rutin, vanillin, vanillic acid, and all 
other high-purity chemicals were acquired from Sigma-Aldrich (St Louis, MO, USA). Nylon 
membranes (47 mm i.d. × 0.45 µm) were used to filter the samples and were purchased from 
São Paulo, Brazil. 
2.2. Fruit material 
     Fresh C. sinensis fruits were collected from agricultural fields of the municipality of 
Cristinápolis, in Sergipe state, Brazil in February 2016 and were authenticated by the botanist 
of the Federal University of Sergipe. The fruits were washed with distilled water and peeled. 
The C. sinensis peels were dried at 40ºC, grounded in a food processor, and immediately 
subjected to the extract preparation process. 
2.3. Extract preparation  
     C. sinensis peels were processed as described by Mishra et al. (2012). 100 mg of fruit peel 
powder were added to methanol (150 mL) and heated at 55°C for 5 min. The solution was 
sealed with a glass stopper and kept on the rotary shaker for 24 h. Finally, the solvent was 
evaporated at 45°C using a rotary evaporator, the extract was reconstituted at 50 mg/mL in 
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methanol and filtered through a membrane filter (0.45 µm). The residues were further dried 
in an oven at 30°C to remove traces of the solvent and stored in an airtight glass container at 
4-5°C until use. After solvent evaporation, the percentage yield of the methanol extract 
obtained from the orange peel was 5.18% (w/w). The extract was dissolved in vehicle 
containing 0.2% polysorbate-80, 0.5% sodium carboxymethyl cellulose, 0.9% sodium 
chloride, 0.9% benzyl alcohol, and 97.5% distilled water (Lee, 2001) and then used for 
experimentation. 
2.4. UHPLC-MS/MS conditions 
    The identification and quantification of phenolic compounds present in C. sinensis peels 
was conducted as described by Andrade et al. (2017). The phenolic profile analysis was 
performed by using a UHPLC system model 1290 Infinity coupled to a 6490 TripleQuad 
mass spectrometer equipped an electrospray ionization system (Agilent Technologies, Palo 
Alto, USA). The chromatographic separations were performed on an Ascentis Express F5 
column, 2.7 µm particle size and 150 × 2.1 mm i.d. (Sigma Aldrich). The mobile phase 
consisted of 0.1% (v/v) aqueous formic acid solution (A) and acetonitrile (B), with a flow rate 
of 0.2 mL/min, eluted with the following gradient profile at 40°C: 0-1 min, 15% B; 1-7 min, 
25% B; 7-9 min, 25% B; 9-13 min, 30% B; 13-16 min, 30% B; 16-21 min, 40% B; 21-23 min, 
40% B; 23-25 min, 45% B; 25-28 min, 50% B; 28-33 min, 60% B; 33-37 min, 75% B; and 37-
38 min, 15% B. The injection volume was 2 µL. The LC-MS data were acquired by using the 
MassHunter software. A standard calibration curve was prepared from eight data points in the 
concentration range of 20-1000 ng/mL. All analyses were performed in triplicate. The 
precision of the replicates was expressed by their relative standard deviation (RSD).  
     The mass spectrometry conditions were: source temperature, 200ºC; gas flow, 12 L/h; 
nebuliser, 20 psi; sheath gas temperature, 400°C; sheath gas flow, 11 L/min; capillary 
voltage, 3500 V; nozzle voltage, 500 V; acceleration cell voltage, 5 V; and dwell time, 9.8 
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ms. To obtain the maximum sensitivity for the identification and detection of all target 
compounds, two selected reaction monitoring transitions were monitored for each compound. 
The electrospray ionization source was operated in positive mode, except for CAPE, for which 
a negative mode was used.  
2.5. Experimental animals   
     All animal procedures were approved in accordance with the Institutional Ethical 
Committee for the use and care of experimentation on animals based on US National 
Institutes of Health Publication. Healthy male Wistar rats (weight: 180-200 g) were housed in 
polypropylene cages, fed a standard chow diet (10% energy from fat, 76% from 
carbohydrates, and 14% from proteins; 3.8 kcal/g), and provided tap water ad libitum. The 
animals were maintained and acclimatised under controlled conditions (temperature, 22°C ± 
2°C; relative humidity, 60% ± 5%) with a 12:12 h light/dark cycle for 7 days after arrival.  
2.6. Acute oral toxicity study  
     Healthy male rats (weight: 180-200 g) were fasted overnight with no prior drug treatments 
and divided equally into three groups of six rats each. CSMe was administered orally at 0.5 
and 1 g/kg concentrations, suspended in a vehicle containing 0.2% polysorbate-80, 0.5% 
sodium carboxymethyl cellulose, 0.9% sodium chloride, 0.9% benzyl alcohol, and 97.5% 
distilled water (3 mL/100 g) for the treatment groups. The control group was administered the 
vehicle (3 mL/100 g) alone. The rats were allowed free access to food and water from 4 h 
after the CSMe administration. All the animals were closely observed for the initial 4 h and 
then every day over a period of 14 days for signs of mortality, drowsiness, restlessness, 
writhing, convulsions, piloerection; analysis of urine and faeces. The animals were sacrificed 
on day 15 and the vital organs were observed for gross pathological lesions. CSMe (0.5 and 1 
g/kg) did not result in any deaths, although mild physiological alterations were observed at 1 
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g/kg. No treatment-associated gross pathological alterations were witnessed. Hence, doses of 
50 and 100 mg were selected for subsequent experiments, based on the results of Oliveira et 
al. (2008). 
2.7. Development of the T2DM model  
     T2DM was induced in experimental rats by feeding a standardised high-fat diet (55% 
energy from fat, 31% from carbohydrates, and 14% from proteins; 5.9 kcal/g) for 2 weeks 
prior to a single intraperitoneal injection of STZ (40 mg/kg) dissolved in 0.1 M citrate buffer 
(pH 4.5). The rats received tap water and the high-fat diet throughout the study. Initial drug-
induced hypoglycaemic mortality was avoided in STZ-injected rats by the administration of a 
20% glucose solution for 24 h. The rats in the non-diabetic control group were injected with 
the citrate buffer solution and received tap water and the commercial chow diet during the 
experiment. Blood samples were collected from the tail vein after 5 days of STZ induction; 
hyperglycaemia was evaluated through the measurement of fasting blood glucose (FBG) 
levels (Trinder, 1969). Rats with FBG > 250 mg/dL were classified as diabetic and used in 
the study. Subsequently, the experiment commenced on day 0 (3 days after the induction of 
diabetes) and the high-fat diet was maintained throughout the study. 
2.8. Experimental design 
     Twenty four diabetic and 6 normal rats were randomly divided into five groups, 
containing six rats each, and administered the following treatments:  
Group I: Normal control rats received vehicle 1 mL/100 g 
Group II: Diabetic control rats received vehicle 1 mL/100 g 
Group III: Diabetic rats treated with CSMe 50 mg/kg suspended in vehicle (1 mL/100 g) 
Group IV: Diabetic rats treated with CSMe 100 mg/kg suspended in vehicle (1 mL/100 g) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
Group V: Diabetic rats treated with metformin 100 mg/kg suspended in vehicle (1 mL/100 g) 
The vehicle or test drugs were administered by gavage between 12.00 and 2.00 p.m, once a 
day, for 30 days. 
2.9. Biochemical analysis 
     The intake of food and water was estimated once per day during the experiment. FBG and 
body weight were measured on days 0, 14, 21, and 28. Plasma insulin, determined by an 
ultrasensitive rat insulin ELISA kit, total cholesterol (TC), triglycerides (TG), high (HDL-c), 
and low-density lipoprotein cholesterol (LDL-c) were determined on days 0 and 28. The 
Homeostasis Model Assessment of insulin resistance (HOMA‐IR) was calculated as 
described by Matthews et al. (1985). An oral glucose tolerance test (OGTT) was conducted 
on day 15. Briefly, the rats were fasted for 6 h and, a glucose solution (2 g/kg) was orally 
administered to each rat 30 min after the administration of the extract, standard drug, or 
vehicle. The blood glucose was analysed at time 0 (prior to the glucose administration) and at 
30, 60, and 120 min after the glucose infusion. On day 25, an insulin tolerance test (ITT) was 
conducted. Briefly, after fasting for 6 h, blood samples were collected from the tail vein into 
heparin-coated tubes. The animals were intraperitoneally administered a dose of 1.2 U/kg 
insulin (Huminsulin R; Eli Lilly) in normal saline. Blood samples were then collected 30 and 
60 min after the insulin injection, from which the glucose level was estimated. On day 30, the 
animals were anaesthetised and sacrificed by cervical decapitation in accordance with animal 
ethics guidelines. The blood was collected in a dry test tube and allowed to coagulate at room 
temperature for 30 min. The serum was then separated by centrifugation at 2000 rpm for 10 
min and serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic 
transaminase (SGPT) were estimated using Reitman and Frankel method (1957). The activity 
of serum alkaline phosphatase (ALP) was determined  using the method of Kind and King 
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(1954). Serum urea and creatinine were measured by using the diacetyl monoxime method 
(Wybenga et al., 1971) and Jaffe’s method (Slot, 1965), respectively. 
2.10. Histology 
     The histology of pancreas and adipose was examined in accordance with previously 
described protocols (Gandhi et al., 2012). 
2.11. Immunohistochemical analysis 
     Pancreatic tissues were fixed in 10% neutral buffered saline, embedded in paraffin, and 
prepared as 5 µm thick sections. The tissues were fixed on a clean microscope slide and 
deparaffinised in a xylene bath. The slides were dehydrated with two rinses in absolute 
alcohol and two rinses in 95% ethanol for 3 min each. The tissue sections were placed in 
0.3% hydrogen peroxide (2 mL H2O2 in 18 mL methanol) and 5% normal bovine serum (1:5 
diluted PBS) for 20 min at room temperature, respectively, to block the endogenous 
peroxidase and non-specific binding sites for antibodies. To detect insulin, the sections were 
incubated with polyclonal guinea-pig anti-insulin (1:250 dilution) and horseradish peroxidase 
(HRP)-conjugated streptavidin for 30 min, respectively. The sections were washed in PBS 
and incubated with biotinylated anti-mouse IgG (1:500 dilution). After incubation for 30 min, 
the sections were washed again with PBS and excess buffer was removed from the slides, 
which were then incubated with diaminobenzidine for 3-5 min at room temperature and then 
washed with distilled water. Finally, the slides were stained with haematoxylin, dehydrated, 
and mounted in glycerin-gelatin (Gandhi et al., 2011). The results were scored through 
multiplication of the percentage of positive cells (P) with the intensity of staining (I). 
Formula: Score = P × I (McDonald and Pilgram, 1999). 
2.12. RNA extraction and reverse transcriptase-polymerase chain reaction (RT-PCR) 
analysis 
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     RT-PCR was performed as described by Lee et al. (2010). Total RNA was isolated from 
adipose tissue by using TRIzol reagent in accordance with the manufacturer’s instructions 
and reverse-transcribed into cDNA. The following gene-specific primers were used: PPARγ, 
5'-TCAGGGCTGCCAGTTTCG-3' (forward), 5'-GCTTTTGGCATACTCTGTGATCTC-3' 
(reverse); GLUT4, 5'-GACATTTGGCGGAGCCTAAC-3' (forward), 5'-
TAACTCCAGCAGGGTGACACAG-3' (reverse); insulin receptor (IR), 5'-
TGACAATGAGGAATGTGGGGAC-3' (forward), 5'-
GGGCAAACTTTCTGACAATGACTG-3' (reverse); β-actin, 5'-
TGTTGTCCCTGTATGCCTCT-3' (forward), 5'-TAATGTCA GCACGATTTCC-3' 
(reverse). The reaction mixtures were resolved on 2% agarose gels, stained with ethidium 
bromide, and photographed.  
2.13. Western blot analysis 
     Total protein (100 µg) extracted from the adipose tissue of the experimental rats was 
suspended in substrate-soluble buffer and resolved by 10% SDS-PAGE. Subsequently, the 
proteins were transferred to a nitrocellulose membrane, which was blocked with 5% non-fat 
dry milk at 4°C for 1 h and probed overnight with primary antibodies for PPARγ, GLUT4, 
IR, and β-actin (which were diluted to 1:1000). After three washes for 5 min each in PBS-
Tween 20 (PBST), the membranes were incubated with HRP-conjugated rabbit-anti mouse or 
goat-anti rabbit secondary antibodies (which were diluted to 1:5000) for 1 h. The obtained 
blots were further washed three times with PBST and the protein band was detected using an 
enhanced chemiluminescence detection system (Mullainadhan et al., 2017).   
2.14. Statistical analysis   
     The results are expressed as the mean ± standard error of the mean (SEM). The statistical 
significance was evaluated by one-way analysis of variance followed by Dunnett’s C post-
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hoc test computed by using SPSS 11.5 for Windows. Differences with a P value of < 0.05 
were considered significant. 
3. Results 
3.1. Quantification of phenolic compounds in CSMe by UHPLC-MS/MS  
     To validate the UHPLC-MS/MS method, calibration curves were run between sample 
analyses. The linearity parameters of method verification are presented in Table 1. The 
external calibration curves were constructed for each standard by plotting the peak area 
versus the nominal concentration. The method verification was in accordance with the 
analytical method validation guidelines (US-FDA, 2000) with regression analysis (r2) values 
above 0.99 (Table 1). The individual compounds were quantified from the ratio of the peak 
areas of the identified compounds relative to the peak areas of the corresponding analytical 
standard. The quantification of the phenol compounds in CSMe are detailed in Table 2 and 
their chemical structures are shown in Figures 2 and 3. The chromatographic profile of CSMe 
is shown in Figure 1A. Seventeen phenolic compounds were identified and quantified in 
CSMe by UHPLC-MS/MS. The target compounds were identified by monitoring of the 
specific fragmentations of each analytical standard and their corresponding retention times. 
The compounds rutin (1248.3 µg/g), p-coumaric acid (957.4 µg/g), protocatechuic acid 
(326.3 µg/g), ferulic acid (316.0 µg/g), and naringenin (220.7 µg/g) of dry weight peel 
(DWP) were the major constituents of CSMe.  
3.2. Effect of CSMe on the intake of food and water in high-fat diet-fed STZ-induced diabetic 
rats 
     High-fat diet-fed STZ-induced diabetic rats exhibited a significant increase in food and 
water consumption compared with normal control rats at the start of the intervention. The 
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treatment with CSMe (50 and 100 mg/kg) significantly reduced food and water intake 
compared with diabetic control rats by the end of the study (Table 3). 
3.3. Effect of CSMe on OGTT and ITT parameters  
     The oral administration of glucose gradually increased the blood glucose level in all 
groups at 30 min, which remained unchanged over the next 120 min in the diabetic control 
rats. In diabetic rats receiving CSMe (50 and 100 mg/kg) or metformin, the blood glucose 
levels decreased at 60, and 120 min after glucose administration, although they remained 
significantly higher than the normal controls at 120 min (Table 4). CSMe (50 and 100 mg/kg) 
treated diabetic rats also had significant clearance of blood glucose over the experimental 
period of the ITT compared with diabetic control rats and reached similar blood glucose 
levels as metformin after 60 min (Table 5). 
3.4. Effect of CSMe on FBG and body weight  
      The FBG levels and body weight of control and experimental rats at 0, 14, 21, and 28 
days of treatment are shown in Tables 6 and 7. CSMe (50 and 100 mg/kg) and metformin 
treated rats significantly decreased FBG levels by 56.1%, 55.6% and 55.7%  respectively, 
after 28 days of treatment compared with the diabetic control rats. Body weight gain was 
significantly higher in high-fat diet-fed STZ-induced diabetic rats than in normal control rats 
during the experimental period. CSMe (50 and 100 mg/kg) treatment resulted in a smaller 
body weight gain in diabetic rats compared with diabetic control rats, but these differences 
were not statistically significant. 
3.5. Effect of CSMe on plasma insulin and HOMA-IR  
     High-fat diet-fed STZ-induced diabetic rats had a significant increase in plasma insulin 
levels and HOMA-IR compared with normal control rats (day 0 of Table 8). CSMe (50 and 
100 mg/kg) and metformin treatment resulted in a significant decrease in the plasma insulin 
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levels (22.9% and 32.7% and 23.2%, respectively) in the diabetic rats. CSMe and metformin 
also decreased the HOMA-IR during the follow up study period (day 28, Table 8). 
3.6. Effect of CSMe on TC, TG, LDL-c, and HDL-c  
     The TC, TG, and LDL-c levels were significantly higher in diabetic control rats than in 
the normal control group. In contrast, HDL-c levels were lower in the diabetic control group 
than in the normal control group. CSMe (50 and 100 mg/kg) and metformin significantly 
reduced the levels of TC, TG, and LDL-c and significantly improved the level of HDL-c 
compared with the diabetic control rats (Figure 4).  
3.7. Effect of CSMe on SGOT, SGPT, ALP, urea, and creatinine  
     The activity and levels of SGOT, SGPT, ALP, urea, and creatinine were significantly 
higher in diabetic control rats than in normal control rats, as shown in figure 5. The 
administration of CSMe (50 and 100 mg/kg) or metformin for 30 days significantly restored 
the activities of SGOT, SGPT, and ALP, and increased the levels of urea and creatinine, with 
the reductions being more marked with CSMe at 100 mg/kg and metformin. 
3.8. Histology and immunohistochemical analysis 
     Histological results are shown in Figures 6 and 7. The pancreatic tissue of diabetic rats 
had degranulated β-cells and widespread vacuolisation with disordered islet architecture. 
High-fat diet-fed STZ-induced diabetic rats exhibited a swollen arrangement of cells in the 
epididymal adipose tissue. In contrast, the tissues in CSMe-treated diabetic rats showed 
normal distributions with apparently regular architecture in adipose tissue and pancreatic 
islets. The immunohistochemical analysis of pancreatic islets is shown in Figure 8. Diabetic 
control rats showed a significant decrease in the intensity of positive staining for insulin 
compared with normal control rats. In contrast, the rats receiving CSMe had a significant 
increase in the intensity of insulin staining compared with diabetic control rats. The 
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immunostaining of insulin in the β-cells of the islet tissues is shown in Figure 9. Diabetic 
control rats had a significant reduction in the level of insulin immunostaining expression 
compared with control rats. Conversely, CSMe-treated rats exhibited a significant increase in 
insulin expression compared with the diabetic control group. 
3.9. Effect of CSMe on expression on PPARγ, GLUT4, and IR in adipose tissue 
     PPARγ, GLUT4, and IR mRNA expression levels in CSMe-treated diabetic groups were 
significantly higher than those in the diabetic control group (Fig. 10A). Similar changes were 
observed in the protein expression of PPARγ, GLUT4, and IR (Fig. 10B).  
4. Discussion 
     T2DM is projected to be one of the major causes of morbidity and mortality in the 21st 
century and novel compounds to improve the metabolism of glucose and the long term 
deleterious effects of diabetes are needed (Jaacks et al., 2016). Earlier studies have 
demonstrated that a combined high-fat diet and a low-dose STZ (40 mg/kg) results in insulin-
resistance in rats, with elevation of plasma lipids (Srinivasan et al., 2005). The high-fat diet 
induces insulin resistance through accumulation of lipids, including free fatty acids, their 
COA esters, and triglycerides in adipose tissues, skeletal muscle, and the liver of 
experimental animals, as well as an oxidative imbalance caused by oxidative stress (Krol and 
Krejpcio, 2011; Veerapur et al., 2012). Low-dose STZ results in the partial destruction of β-
cells, which may be responsible for the long-term glycaemic imbalance in rats (Zhang et al., 
2010). Polyphenols of plant origin may have pharmacological properties, as adjuvants for the 
management of symptoms and biomarkers of patients with T2DM (Bahadoran et al., 2013). 
     In the present study, a methanolic orange peel extract, which is rich in polyphenols, 
resulted in significant glucose-lowering effects in diabetic rats compared with a diabetic 
control group when challenged in a OGTT and ITT experiments. These results were similar 
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to those elicited by metformin, which is one of the most commonly used drugs for diabetes 
management. CSMe may have increased the glucose uptake by improving insulin sensitivity 
through a glucose-utilising effect in the peripheral tissues. CSMe significantly restored the 
insulin levels and HOMA-IR compared with the diabetic control rats, which signifies that its 
insulin-sensitising effects may be associated through a decrease in insulin resistance. 
     As expected, STZ-induced diabetic rats receiving a high-fat diet had significant 
hyperglycaemia compared with normal control rats. CSMe significantly reduced the FBG 
level in diabetic rats by improving the physiological functions of PPARγ in adipose tissue. 
CSMe upregulated the expression levels of PPARγ, GLUT4, and IR in the adipose tissues of 
diabetic rats. These findings showed that CSMe-mediated PPARγ activation stimulated 
adipocyte differentiation and enhanced IR signalling via the translocation and activation of 
GLUT4 in PI3K/p-Akt pathway in the adipose tissue. These results corroborate similar 
findings by Mohammadi et al. 2014. Indeed, Zataria multiflora, a plant containing extensive 
phenol compounds was determined to be a PPARγ agonist, improving insulin-sensitizing 
activity and increase in translocation and activation of GLUT4 in high fructose fed insulin 
resistant rats. 
     The UHPLC-MS/MS also showed that CSMe contains major polyphenol components 
such as rutin, p-coumaric acid, protocatechuic acid, ferulic acid, and naringenin, which, in 
total, comprised 3.7438 mg of the dry weight peel in addition to other minor biophenolics, 
such as apigenin, artepillin C, cinnamic acid, caffeic acid, CAPE, (+)-catechin, ethyl gallate, 
kaempferide, chrologenic acid, acacetin, vanillin, and vanillic acid. It is thus likely, a 
combination of these compounds could be responsible for the antidiabetic activity of CSMe. 
Our results are in agreement with an earlier report that described the synergistic 
hypoglycaemic and insulin-sensitising effect of phenolic constituents derived from Aristotelia 
chilensis in T2DM mice (Rojo et al., 2012). Although the overall mechanism of the CSMe-
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mediated reversal of hyperglycaemia has not been elucidated, our findings may suggest the 
phenolic constituents exert potent synergistic action on the PPARγ receptor, stimulate 
GLUT4 translocation and activate via an insulin-dependent pathway in adipose tissue, and 
reduce glucose levels in blood.  
     Our results demonstrated that the combination of a high-fat diet and STZ markedly 
increased the levels of TC, TG, LDL-c, and decreased that of HDL-c. Hyperlipidaemia is a 
crucial factor in the pathophysiology of T2DM, which is responsible for severe diabetic 
complications (Verges, 2015). The increased TG levels and decreased HDL-c levels in 
diabetic rats may result from their larger high-fat diet intake. The enlargement of epidydimal 
adipose cells and increase in body weight gain were also observed in the high-fat diet fed 
diabetic rats. The administration of CSMe to diabetic rats markedly improved the lipid 
profile, the altered glycaemia and the morphological variations in adipose tissue. These 
observations are in agreement with Sharma et al. (2015) who reported that phenolic-rich 
extracts of Brassica oleracea var gongylodes act as a multi-component extract therapy that 
exhibits a marked control on the lipid profile and blood glucose levels. The findings of the 
study also demonstrated that the extract affected the antioxidative capacity in the diabetic 
condition. 
     The increase in SGOT, SGPT, and ALP might reflect the outflow of these enzymes from 
the liver cytosol into the blood stream (Navarro et al., 1993). CSMe treatment decreased 
these enzymes levels compared with the diabetic control group and alleviated the liver injury 
caused by high-fat diet fed STZ. In diabetic rats, increased levels of urea and creatinine were 
observed in the serum (Bethesda, 2001) and diabetic rats treated with CSMe exhibited a 
reduction in serum urea and creatinine. The depletion of renal status in diabetic rats was 
caused by the production of reactive oxygen species as an outcome of the elevated free 
radical concentration in these tissues (Fakhruddin et al., 2017). CSMe restored the renal 
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condition in treated diabetic rats, possibly through the neutralisation of free radicals. Gandhi 
et al. (2014) reported that high-fat diet fed STZ-induced diabetes disrupts the function of β-
cells in experimental rats and we found marked degranulation, decreased β-cell mass, and 
reduced insulin expression in the diabetic control group. The oral supplementation of CSMe 
preserved β-cell integrity and increased insulin expression, thus implying that CSMe exerted 
a cytoprotective effect with the reversal of β-cell damage caused by STZ. 
5. Conclusion 
     The present study suggests that phenolic-rich CSMe confers an insulin-sensitising effect 
on high-fat diet-fed STZ-induced diabetic rats, which improved the upregulation of PPARγ, 
GLUT4, and IR in the adipose tissue. CSMe has therapeutic potential against dyslipidaemia; 
which may be accompanied by protective effects on the structure and function of β-cell. 
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     Table 1: Method verification linearity 
Phenolic Equation r2 Retention 
time (min) 
Acacetin y = 6587 + 69212 x 0.998 24.2 
Apigenin y = 11116 + 2146 x – 0.4294 x2 0.999 17.7 
Artepillin C y = 12979 +1680 x + 0.7351 x2 0.995 29.3 
Cinnamic acid y = 1139 – 10095 x 0.998 11.55 
Caffeic acid y = 433.1 – 558.4 0.998 4.4 
Caffeic acid phenyl ester 
(CAPE) 
y = 121.8 – 565.1 x 0.999 23.3 
(+)-Catechin y = 1460 – 2538 x 0.998 3.1 
Ethyl gallate y = 976.8 – 6209 x 0.998 5.6 
Chlorogenic acid y = 10531 – 57618 x 0.996 3.16 
Kaempferide y = 1296 – 6160 x 0.997 24.31 
Naringenin y = 3146 – 7237 x 0.998 16.04 
p-Coumaric acid y = 971.3 – 6661 x 0.997 6.51 
Protocatechuic acid y = 414.6 – 2985 x 0.997 2.80 
Ferulic acid y = 2811 – 28884 x 0.997 7.47 
Rutin y = 840.7 – 3036 x 0.997 6.46 
Vanillin y = 9927 – 72786 x 0.998 6.51 
Vanillic acid y = 20015 – 3631 x + 0.4320 x2 0.996 4.57 
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Table 2: Concentration in µg/g of dry weight peel (DWP) and relative standard 
deviation (RSD) of the phenolic compounds in orange peel 
Phenolic Concentration (µg/g DWP) RSD (%) 
Acacetin 2.34 2.0 
Apigenin 44.6 3.6 
Artepillin C 3.13 10.6 
Caffeic acid 43.3 8.8 
CAPE 17.3 7.7 
(+)-Catechin 23.1 14.2 
Chrologenic acid 5.01 4.8 
Cinnamic acid 183.0 11.7 
Ethyl gallate 116.0 8.8 
Ferulic acid 316.0 12.6 
Kaempferide 35.4 5.0 
Naringenin 220.7 8.7 
p-Coumaric acid 957.4 11.4 
Protocatechuic acid 326.3 9.1 
Rutin 1248.3 7.3 
Vanillin 89.8 8.1 
Vanillic acid 112.2 10.2 
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Table 3: Effect of CSMe on the intake of food and water in high-fat diet-fed STZ-induced 
diabetic rats 
Groups Food intake (g/rat/day)                         Water intake (mL/rat/day) 
 
Day 0                  Day 30                       Day 0                   Day 30   
Normal control 13.6 ± 2.9 16.2 ± 4.1 77.8 ± 4.1 82.6 ± 5.1 
 
Diabetic control 43.4 ± 9.2a 58.6 ± 8.8a 151.6 ±11.2a 182.6 ± 10.2a 
Diabetic + 
CSMe (50 mg/kg) 
38.6 ± 5.4a 27.9 ± 6.1a,b 144.5 ± 9.1a 111.9 ± 10.4a,b 
Diabetic + 
CSMe (100 mg/kg) 
39.8 ± 7.2a 23.1 ± 5.1a,b 145.7 ± 8.6a 91.1 ± 8.4a,b 
Diabetic + 
Metformin (100 mg/kg) 
 
42.9 ± 8.1a 22.1 ± 4.7 a,b 143.6 ± 7.9a 95.9 ± 8.4a,b 
The values indicate the mean ± SEM of six rats per group  
aP < 0.05, compared with normal control values; 
bP < 0.05, compared with diabetic control values. 
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Table 4: Effect of CSMe on OGTT in high-fat diet-fed STZ-induced diabetic rats 
Groups Blood glucose level (mg/dL) 
                                                                                                                             
0 min                      30 min                     60 min                 120 min 
Normal control 134.9 ± 6.2 176.5 ± 5.1  175.4 ± 6.2 141.3 ± 6.8 
 
Diabetic control 323.8 ± 12.8a 382.6 ± 7.4a 394.2 ± 10.2a 326.3 ± 12.4a 
Diabetic + 
CSMe (50 mg/kg) 
222.8 ± 7.8a,b 283.6 ± 7.9a,b 241.9 ± 11.4a,b 232.5 ± 13.1a,b 
Diabetic + 
CSMe (100 mg/kg) 
231.9 ± 7.9a,b 275.8 ± 8.8 a,b 238.6 ± 12.27 a,b 235.1 ± 6.8a,b 
Diabetic + 
Metformin (100 mg/kg) 
 
235.4 ± 10.1a,b 276.5 ± 10.9a,b 240.6 ± 10.6 a,b 231.9 ± 8.4a,b 
The values indicate the mean ± SEM of six rats per group  
aP < 0.05, compared with normal control values; 
bP < 0.05, compared with diabetic control values. 
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Table 5: Effect of CSMe on ITT in high-fat diet-fed STZ-induced diabetic rats 
Groups                               Blood glucose level (mg/dL) 
 
 0 min                     30 min                    60 min 
Normal control 135.8 ± 4.2 105.8 ± 6.3  102.5 ± 5.2 
Diabetic control 324.2 ± 12.8a 337.9 ± 9.4a 340.5 ± 8.2a 
Diabetic + 
CSMe (50 mg/kg) 
142.5 ± 9.3b 112.8 ± 8.1b 122.8 ± 7.6b 
Diabetic + 
CSMe (100 mg/kg) 
122.9 ± 5.5b 106.8 ± 9.7b 116.8 ± 7.5b 
Diabetic + 
Metformin (100 mg/kg) 
 
132.5 ± 7.4b 108.5 ± 8.6b 118.6 ± 6.2b 
 The values indicate the mean ± SEM of six rats per group 
aP < 0.05, compared with normal control values; 
bP < 0.05, compared with diabetic control values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
29 
 
Table 6: Effect of CSMe on FBG in high-fat diet-fed STZ-induced diabetic rats 
Groups 
 
FBG level (mg/dL) 
 Day 0                    Day 14                   Day 21                   Day 28   
Normal control 107.2 ± 6.4 123.8 ± 9.2 132.8 ± 4.6 135.9 ± 8.4 
Diabetic control 274.8 ± 6.2a 318.5 ± 9.5a 328.8 ± 10.2a 342.9 ± 11.6a 
Diabetic + 
CSMe (50 mg/kg) 
283.2 ± 14.2a 236.1 ± 7.1a,b 155.6 ± 10.7a,b 124.2 ± 8.6b 
Diabetic + 
CSMe (100 mg/kg) 
290.6 ± 8.8a 228.5 ± 6.8a,b 142.8 ± 9.9b  128.8 ± 4.8b 
Diabetic + 
Metformin (100 mg/kg) 
292.6 ± 6.8a 230.6 ± 8.7a,b 149.9 ± 10.4b 129.6 ± 8.2b 
The values indicate the mean ± SEM of six rats per group  
aP < 0.05, compared with normal control values; 
bP < 0.05, compared with diabetic control values. 
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Table 7: Effect of CSMe on body weight in high-fat diet-fed STZ-induced diabetic rats 
 
Groups 
 
Body weight (g) 
 Day 0                     Day 14                   Day 21                 Day 28   
Normal control 186.8 ± 12.2 188.2 ± 13.8 192.8 ± 13.6 197.6 ± 14.8 
Diabetic control 192.8 ± 10.8 217.9 ± 13.5a 228.8 ± 14.1a 237.8 ± 12.2a 
Diabetic +  
CSMe (50 mg/kg) 
197.4 ± 14.8 210.5 ± 9.8a 218.6 ± 12.2a 214.2 ± 12.9a 
Diabetic +  
CSMe (100 mg/kg) 
181.6 ± 12.1 208.4 ± 10.2a 213.6 ± 14.2a 219.5 ± 10.8a 
Diabetic + Metformin 
(100 mg/kg) 
202.9 ± 8.2a 217.4 ± 13.2a 222.7 ± 12.6a  216.6 ± 11.2a 
The values indicate the mean ± SEM of six rats per group  
aP < 0.05, compared with normal control values. 
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Table 8: Effect of CSMe on plasma insulin and HOMA-IR in high-fat diet-fed STZ-induced 
diabetic rats 
Groups 
 
Plasma insulin (µU/mL)                           HOMA-IR 
 
Day 0                    Day 28                    Day 0                   Day 28   
Normal control 16.1 ± 1.2  15.8 ± 0.7 4.3 ± 0.6  5.4 ± 0.6 
Diabetic control 20.9 ± 0.7a  25.8 ± 1.3a 14.6 ± 2.2a         21.4 ± 1.4a           
Diabetic + 
CSMe (50 mg/kg) 
21.8 ± 0.8a 16.8 ± 1.2b 15.4 ± 1.2a 5.8 ± 0.9b            
Diabetic + 
CSMe (100 mg/kg) 
22.0 ± 1.6a 14.8 ± 0.5b 15.6 ± 1.6a 5.4 ± 0.6b  
Diabetic + 
Metformin (100 mg/kg) 
20.7 ± 1.4a 15.9 ± 0.5b 14.9 ± 1.6a 5.2 ± 0.8b 
The values indicate the mean ± SEM of six rats per group  
aP < 0.05, compared with normal control values; 
bP < 0.05, compared with diabetic control values. 
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Figure captions 
Fig. 1. Total ion chromatogram of methanol extract from Citrus sinensis fruit peel (CSMe) (A); 
chromatogram obtained in selected reaction monitoring (Quantization Transition) mode for pure 
standards (B) 
Figs. 2 & 3. Chemical structures of phenolic compounds identified and quantified from methanol 
extract from Citrus sinensis fruit peel (CSMe).  
Fig. 4.  Effect of CSMe on TC (A), TG (B), LDL-c (C), and HDL-c (D) in high-fat diet-fed STZ-
induced diabetic rats. The bar represented the mean ± SEM of six rats per group.  
a compared with normal control group (P < 0.05); b compared with diabetic control group (P < 
0.05). 
Fig. 5.  Effect of CSMe on SGOT (A), SGPT (B), ALP (C), urea (D), and creatinine (E) in high-
fat diet-fed STZ-induced diabetic rats. The bar represented the mean ± SEM of six rats per 
group.  
a compared with normal control group (P < 0.05); b compared with diabetic control group 
(P<0.05). 
Fig. 6. Histopathological changes in the pancreatic islet tissues of experimental rats (H & E, 
scale Bar: 50 µm, 40×)     
(A) Normal control: H & E-stained sections of the pancreas of normal control rats. Yellow 
arrows indicate the normal islets of Langerhans 
(B) Diabetic control: Pancreatic section of high-fat diet-fed streptozotocin (STZ)-induced 
diabetic rats. Fewer islets of Langerhans and β-cells are seen (black arrows) 
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(C, D) Diabetic + (CSMe; 50 and 100 mg/kg): Pancreatic sections of diabetic rats treated with 
CSMe. Normal pancreatic islets of Langerhans and enhanced numbers of β-cells are seen (yellow 
arrows) 
(E) Diabetic + Metformin (100 mg/kg): Pancreatic sections of diabetic rats treated with 
metformin. Increased numbers of islets of Langerhans and appropriate proportions of β-cells are 
seen (yellow arrows)  
Fig. 7. Histological interpretations of adipose tissues of experimental rats (H & E, scale bar = 50 
µm, 40×)   
(A) Normal control: H & E-stained sections of normal control rat indicating the usual and 
regular distribution of cellular types in adipose tissue  
(B) Diabetic control: Tissue sections of high-fat diet-fed STZ-induced diabetic rats showing 
regressed and unusual distribution of cellular types in adipose tissue (C, D) Diabetic + (CSMe; 
50 and 100 mg/kg) : Stained sections of diabetic rats treated with CSMe indicating normal and 
regular distributions of cellular types in adipose tissue (E) Diabetic + Metformin (100 mg/kg): 
Section of diabetic rats treated with metformin showing usual distribution of cellular types in 
adipose tissue  
Fig. 8. Light micrograph showing the intensity of immunostaining for insulin containing β-cells 
in the islets of Langerhans (scale bar = 50 µm, 40×)   
(A) Normal control: Islet tissue section of normal control rats showing positive insulin 
containing β-cells 
 (B) Diabetic control: Islet tissue sections of high-fat diet-fed STZ-induced diabetic rats showing 
decreased positive staining for insulin containing β-cells 
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 (C, D) Diabetic + (CSMe; 50 and 100 mg/kg) : Islet tissue sections of diabetic rats treated with 
CSMe showing increased and adequate positive insulin containing β-cells 
(E) Diabetic + Metformin (100 mg/kg): Islet tissue sections of diabetic rats treated with 
metformin showing better and sufficient positive insulin containing β-cells  
Fig. 9. Histogram showing intensity of immunostaining for insulin containing β-cells in the islets 
of Langerhans 
(A) Normal control, (B) Diabetic control, (C) Diabetic + CSMe (50 mg/kg), (D) Diabetic + 
CSMe (100 mg/kg), (E) Diabetic + Metformin (100 mg/kg) 
Bars represent the mean ± SEM of six rats per group  
a compared with normal control group (P < 0.05); b compared with diabetic control group 
(P<0.05). 
Fig. 10A. Effects of CSMe on the mRNA expressions of PPARγ, GLUT4, IR, and β-actin in 
adipose tissue of experimental animals. (Lane 1) Normal control, (Lane 2) Diabetic control, 
(Lane 3) Diabetic + CSMe (50 mg/kg), (Lane 4) Diabetic + CSMe (100 mg/kg).  
The bars represent the mean ± SEM of three independent experiments. 
a compared with normal control group (P < 0.05); b compared with diabetic control group 
(P<0.05). 
Fig. 10B. Effects of CSMe on the protein expressions of PPARγ, GLUT4, IR, and β-actin in the 
adipose tissue of experimental animals. (Lane 1) Normal control, (Lane 2) Diabetic control, 
(Lane 3) Diabetic + CSMe (50 mg/kg), (Lane 4) Diabetic + CSMe (100 mg/kg). 
The bars represented the mean ± SEM of three independent experiments. 
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a compared with normal control group (P < 0.05); b compared with diabetic control group 
(P<0.05). 
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Highlights 
 
• Citrus sinensis peel methanol extract lowered blood glucose level in diabetic rats 
• Citrus sinensis peel contained fine concentrations of phenolic compounds 
• Citrus sinensis peel possessed cytoprotective action 
• Citrus sinensis peel promoted insulin receptor signaling  
 
